Ask Me Anything Part 25: Sleep Talking, Long Covid, CBD/CBN, and Bedroom Environment

Sleep talking, or somniloquy, is a parasomnia, a disorder occurring in or around sleep. It is the most common parasomnia, affecting a significant majority of people at some point in their lives, particularly children, with prevalence decreasing in adulthood. The content of sleep talking varies depending on the sleep stage. During REM sleep, speech tends to be more emotional and narrative, often recounting dream experiences. However, during non-REM sleep, especially Stage 2, sleep talking is typically mundane, fragmented, and incoherent, consisting of a few words that don't make much sense. The speaker emphasizes that sleep talking rarely reveals true secrets or thoughts reliably, debunking a common Hollywood trope.

Sleep disturbance is a common and persistent symptom of Long COVID, affecting approximately 50% of individuals, a rate significantly higher than in the general population. These sleep issues can last for several months after the initial infection, though there appears to be a remission curve over time. Studies on Long COVID patients in sleep laboratories reveal fragmented sleep, increased time awake at night, and reduced sleep efficiency. Additionally, REM sleep quality and timing within the sleep cycle may be altered. There's also a higher prevalence of breathing-related sleep disorders, particularly central sleep apnea, in Long COVID patients, likely due to respiratory physiology disruptions rather than airway collapse. The severity of sleep disruption in Long COVID correlates with cognitive impairment and elevated inflammatory markers like interleukin-6 and C-reactive protein.

The speaker addresses the growing market of CBD and CBN products for sleep, noting that the scientific evidence is far less conclusive than marketing suggests. Early reviews of CBN (cannabinol) found insufficient evidence, with most supporting studies being small and outdated, lacking clinical trials with validated sleep measures. More recent rigorous placebo-controlled trials for CBN (e.g., 20mg) showed a reduction in nighttime awakenings and sleep disturbance severity, but the overall effect on sleep quality was small. Interestingly, adding CBD to CBN offered no additional benefit. Dose-response studies for CBN (25-100mg) showed improved sleep quality relative to placebo, but no significant difference compared to melatonin, which itself has mixed evidence for efficacy. For CBD, a 2024 study found subjective sleep improvement in 50-75% of users, but again, adding CBN didn't enhance these effects. A systematic review of medical cannabis (including THC, CBD, CBN) found no robust long-term benefits for sleep problems. A UK registry study showed initial dramatic improvements in sleep and anxiety with cannabis use, but by 18 months, most benefits were lost, while THC and CBD doses had increased by 500% and 900% respectively, indicating rapid tolerance development. The speaker concludes that while higher doses of CBN (50-100mg) might offer some specific, small benefits, it's not a 'magic bullet' and tolerance is a significant concern. He advises prioritizing good sleep hygiene and CBT-I over cannabinoids.

While temperature is a well-known factor for optimal sleep (ideally 67-68°F or 18.5°C, slightly warmer for older adults), several other environmental elements significantly impact sleep quality. Air quality is critical; CO2 levels above 1000 parts per million have been shown to impair sleep and next-day cognitive function. Good ventilation is a simple way to improve CO2 clearance. Humidity between 40-60% is optimal, as overly dry air can irritate airways, leading to discomfort and sleep disruption. Volatile organic compounds (VOCs) from furniture or paint have some correlational evidence with poor sleep, but robust studies are lacking. Mattress quality is important, with medium-to-firm mattresses generally recommended, and natural materials like cotton and wool offering better temperature regulation than synthetics. Mattresses older than 7 years are often associated with poorer sleep due to deterioration. The impact of electromagnetic fields (EMFs) from devices like mobile phones on sleep at typical household levels is not supported by robust evidence; however, phone use in bed significantly disrupts sleep due to psychological factors like doom-scrolling and FOMO. Finally, sound is a major disruptor; ambient noise should ideally be below 30 dB. White or pink noise can be effective for masking disruptive sounds in noisy environments. The speaker emphasizes that while these factors are important, sleep consistency (regular bed and wake times) remains the most impactful behavioral intervention.